AstraZeneca's China President and EVP Leon Wang Under Investigation; Shares Drop 3.5%

Oct 30, 2024, 02:00 PM

AstraZeneca announced at 9:00am that its China President and Executive Vice President of International, Leon Wang, is currently under investigation by Chinese authorities and is cooperating with the inquiry. The company's China operations will continue under the leadership of the current general manager. Following the announcement, AstraZeneca's shares dropped by 3.5%.